Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
NCT06025240
Behavior, Diagnosis
Liverpool, Merseyside, United Kingdom
View Trial DetailsNCT Number: NCT04811417
Frailty is common among chronic kidney disease patients who are on the kidney transplant (KT) waiting list.
The aim of this study is to assess frailty according to different frailty tools among KT candidates and to establish potential biomarkers of frailty.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
This is an observational study where KT candidates will be assessed for frailty according to:
Sociodemographics and clinical variables will be collected and serum samples will be obtained in order to implement further studies regarding biomarkers of frailty..
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2015-2020
Prevalence of frailty according FRIED and FRAIL scale
Time frame: 2015-2020
Serum samples for biomarkers
Parc de Salut Mar
Other
Frailty Assessment Among Kidney Transplant Candidates on the Waiting List
Acronym: Mar-Kid
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06025240
Behavior, Diagnosis
Liverpool, Merseyside, United Kingdom
View Trial DetailsNCT06379009
Frailty, Kidney Transplant; Complications
Oslo, Norway
View Trial DetailsNCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsNCT05629728
Frailty, Pathologic Processes
Daejeon, South Korea
View Trial Details